2023-07-012024-06-302024-06-30false07634634Active Healthcare Solutions Limited2025-03-27falseiso4217:GBPxbrli:pure076346342023-07-01076346342024-06-30076346342023-07-012024-06-30076346342022-07-01076346342023-06-30076346342022-07-012023-06-3007634634bus:SmallEntities2023-07-012024-06-3007634634bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3007634634bus:AbridgedAccounts2023-07-012024-06-3007634634bus:PrivateLimitedCompanyLtd2023-07-012024-06-3007634634core:WithinOneYear2024-06-3007634634core:AfterOneYear2024-06-3007634634core:WithinOneYear2023-06-3007634634core:AfterOneYear2023-06-3007634634core:ShareCapital2024-06-3007634634core:SharePremium2024-06-3007634634core:RevaluationReserve2024-06-3007634634core:OtherReservesSubtotal2024-06-3007634634core:RetainedEarningsAccumulatedLosses2024-06-3007634634core:ShareCapital2023-06-3007634634core:SharePremium2023-06-3007634634core:RevaluationReserve2023-06-3007634634core:OtherReservesSubtotal2023-06-3007634634core:RetainedEarningsAccumulatedLosses2023-06-3007634634core:LandBuildings2024-06-3007634634core:PlantMachinery2024-06-3007634634core:Vehicles2024-06-3007634634core:FurnitureFittings2024-06-3007634634core:OfficeEquipment2024-06-3007634634core:NetGoodwill2024-06-3007634634core:IntangibleAssetsOtherThanGoodwill2024-06-3007634634core:ListedExchangeTraded2024-06-3007634634core:UnlistedNon-exchangeTraded2024-06-3007634634core:LandBuildings2023-06-3007634634core:PlantMachinery2023-06-3007634634core:Vehicles2023-06-3007634634core:FurnitureFittings2023-06-3007634634core:OfficeEquipment2023-06-3007634634core:NetGoodwill2023-06-3007634634core:IntangibleAssetsOtherThanGoodwill2023-06-3007634634core:ListedExchangeTraded2023-06-3007634634core:UnlistedNon-exchangeTraded2023-06-3007634634core:LandBuildings2023-07-012024-06-3007634634core:PlantMachinery2023-07-012024-06-3007634634core:Vehicles2023-07-012024-06-3007634634core:FurnitureFittings2023-07-012024-06-3007634634core:OfficeEquipment2023-07-012024-06-3007634634core:NetGoodwill2023-07-012024-06-3007634634core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3007634634core:ListedExchangeTraded2023-07-012024-06-3007634634core:UnlistedNon-exchangeTraded2023-07-012024-06-3007634634core:MoreThanFiveYears2023-07-012024-06-3007634634core:Non-currentFinancialInstruments2024-06-3007634634core:Non-currentFinancialInstruments2023-06-3007634634dpl:CostSales2023-07-012024-06-3007634634dpl:DistributionCosts2023-07-012024-06-3007634634core:LandBuildings2023-07-012024-06-3007634634core:PlantMachinery2023-07-012024-06-3007634634core:Vehicles2023-07-012024-06-3007634634core:FurnitureFittings2023-07-012024-06-3007634634core:OfficeEquipment2023-07-012024-06-3007634634dpl:AdministrativeExpenses2023-07-012024-06-3007634634core:NetGoodwill2023-07-012024-06-3007634634core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3007634634dpl:GroupUndertakings2023-07-012024-06-3007634634dpl:ParticipatingInterests2023-07-012024-06-3007634634dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3007634634core:ListedExchangeTraded2023-07-012024-06-3007634634dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3007634634core:UnlistedNon-exchangeTraded2023-07-012024-06-3007634634dpl:CostSales2022-07-012023-06-3007634634dpl:DistributionCosts2022-07-012023-06-3007634634core:LandBuildings2022-07-012023-06-3007634634core:PlantMachinery2022-07-012023-06-3007634634core:Vehicles2022-07-012023-06-3007634634core:FurnitureFittings2022-07-012023-06-3007634634core:OfficeEquipment2022-07-012023-06-3007634634dpl:AdministrativeExpenses2022-07-012023-06-3007634634core:NetGoodwill2022-07-012023-06-3007634634core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3007634634dpl:GroupUndertakings2022-07-012023-06-3007634634dpl:ParticipatingInterests2022-07-012023-06-3007634634dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3007634634core:ListedExchangeTraded2022-07-012023-06-3007634634dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3007634634core:UnlistedNon-exchangeTraded2022-07-012023-06-3007634634core:NetGoodwill2024-06-3007634634core:IntangibleAssetsOtherThanGoodwill2024-06-3007634634core:LandBuildings2024-06-3007634634core:PlantMachinery2024-06-3007634634core:Vehicles2024-06-3007634634core:FurnitureFittings2024-06-3007634634core:OfficeEquipment2024-06-3007634634core:AfterOneYear2024-06-3007634634core:WithinOneYear2024-06-3007634634core:ListedExchangeTraded2024-06-3007634634core:UnlistedNon-exchangeTraded2024-06-3007634634core:ShareCapital2024-06-3007634634core:SharePremium2024-06-3007634634core:RevaluationReserve2024-06-3007634634core:OtherReservesSubtotal2024-06-3007634634core:RetainedEarningsAccumulatedLosses2024-06-3007634634core:NetGoodwill2023-06-3007634634core:IntangibleAssetsOtherThanGoodwill2023-06-3007634634core:LandBuildings2023-06-3007634634core:PlantMachinery2023-06-3007634634core:Vehicles2023-06-3007634634core:FurnitureFittings2023-06-3007634634core:OfficeEquipment2023-06-3007634634core:AfterOneYear2023-06-3007634634core:WithinOneYear2023-06-3007634634core:ListedExchangeTraded2023-06-3007634634core:UnlistedNon-exchangeTraded2023-06-3007634634core:ShareCapital2023-06-3007634634core:SharePremium2023-06-3007634634core:RevaluationReserve2023-06-3007634634core:OtherReservesSubtotal2023-06-3007634634core:RetainedEarningsAccumulatedLosses2023-06-3007634634core:NetGoodwill2022-07-0107634634core:IntangibleAssetsOtherThanGoodwill2022-07-0107634634core:LandBuildings2022-07-0107634634core:PlantMachinery2022-07-0107634634core:Vehicles2022-07-0107634634core:FurnitureFittings2022-07-0107634634core:OfficeEquipment2022-07-0107634634core:AfterOneYear2022-07-0107634634core:WithinOneYear2022-07-0107634634core:ListedExchangeTraded2022-07-0107634634core:UnlistedNon-exchangeTraded2022-07-0107634634core:ShareCapital2022-07-0107634634core:SharePremium2022-07-0107634634core:RevaluationReserve2022-07-0107634634core:OtherReservesSubtotal2022-07-0107634634core:RetainedEarningsAccumulatedLosses2022-07-0107634634core:AfterOneYear2023-07-012024-06-3007634634core:WithinOneYear2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3007634634core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3007634634core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3007634634core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3007634634core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3007634634core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3007634634bus:Director12023-07-012024-06-3007634634bus:Director22023-07-012024-06-3007634634bus:Director32023-07-012024-06-3007634634bus:Director42023-07-012024-06-3007634634bus:Director52023-07-012024-06-30

Active Healthcare Solutions Limited

Registered Number
07634634
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

Active Healthcare Solutions Limited
Company Information
for the year from 1 July 2023 to 30 June 2024

Directors

B Atkinson-Willes
S Black
M Collis
L Mclean Wait
PM Oostlander

Company Secretary

B Atkinson-Willes

Registered Address

72 Leonard Street
London
EC2A 4QX

Registered Number

07634634 (England and Wales)
Active Healthcare Solutions Limited
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3362,204335,772
Tangible assets45,2397,126
367,443342,898
Current assets
Stocks450,099327,611
Debtors5394,970497,233
Cash at bank and on hand8,2707,692
853,339832,536
Creditors amounts falling due within one year(640,111)(589,378)
Net current assets (liabilities)213,228243,158
Total assets less current liabilities580,671586,056
Creditors amounts falling due after one year(368,193)(313,418)
Net assets212,478272,638
Capital and reserves
Called up share capital188188
Share premium2,124,0042,124,004
Other reserves864,412396,162
Profit and loss account(2,776,126)(2,247,716)
Shareholders' funds212,478272,638
The financial statements were approved and authorised for issue by the Board of Directors on 27 March 2025, and are signed on its behalf by:
B Atkinson-Willes
Director
Registered Company No. 07634634
Active Healthcare Solutions Limited
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially recognised at cost. After initial recognition, intangible assets are measured at cost less and accumulated amortisation and impairment losses. Patents and Licenses are being amortised evenly over their estimated useful life of ten years. Product development costs are being amortised over their estimated useful life of five years. Website development costs are being amortised over their estimated useful life of five years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Office Equipment-3
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year1012
3.Intangible assets

Total

£
Cost or valuation
At 01 July 23585,798
Additions155,385
At 30 June 24741,183
Amortisation and impairment
At 01 July 23250,025
Charge for year128,954
At 30 June 24378,979
Net book value
At 30 June 24362,204
At 30 June 23335,772
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 July 2336,824
Additions1,541
At 30 June 2438,365
Depreciation and impairment
At 01 July 2329,699
Charge for year3,427
At 30 June 2433,126
Net book value
At 30 June 245,239
At 30 June 237,126
5.Debtors: amounts due after one year

2024

2023

££
Deferred tax asset, debtors142,000158,000
Total142,000158,000
Following a period of losses, as the company developed products for sale, the directors consider that the company will be profitable in future years and will be in a position to utilise the tax losses accumulated to date. The directors have reviewed the recoverability of the tax loss and have reduced the deferred tax asset by £16,000 to £142,000 in the year to 30 June 2024.
6.Other commitments
The company had total guarantees, contingencies and commitments at the end of the year of £21,667 (2023 £73,667).
7.Further information regarding the company's financial position
Included within creditors is the bank overdraft £51,180 (2023: £50,219). This debt is secured with a fixed and floating charge over all assets.